Organization
Mannheim Cancer Center (MCC)
2 abstracts
Abstract
RINGSIDE phase 2/3 trial of AL102 for treatment of desmoid tumors (DT): Phase 2 results.Org: Memorial Sloan Kettering Cancer Center, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Michigan Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, City of Hope Comprehensive Cancer Center, University of California Los Angeles Translational Oncology Research,
Abstract
Impact of nirogacestat on pain, a key symptom in patients with desmoid tumors (DT): Results from the phase 3 DeFi study.Org: IQVIA Inc., Bratislava, Slovakia, IQVIA, Amsterdam, Netherlands, SpringWorks Therapeutics, Universität Heidelberg, Mannheim Cancer Center (MCC),